Abstract
When large human breast cancers were assayed for oestrogen receptors at multiple sites, 5-fold differences were found in the numbers of oestrogen receptors, between the site within a tumour. This may result from variations in the cell:stroma ratio from site to site. Such differences could be significant when receptor levels in the tumour are low (less than 50 fmol oestradiol bound mg cytosol protein) since the classification distinction between hormone-sensitive and hormone-insensitive breast cancers is based upon numbers of oestrogen receptors detected by the assay. This problem might be remedied by assessment of the cell:stroma ratio in all assayed tumours, and by the combination of the cytoplasmic oestrogen-receptor assay with other hormone-receptor assays.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Braunsberg H. Factors influencing the estimation of oestrogen receptors in human malignant breast tumours. Eur J Cancer. 1975 Jul;11(7):499–507. doi: 10.1016/0014-2964(75)90152-8. [DOI] [PubMed] [Google Scholar]
- Hawkins R. A., Hill A., Freedman B. A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta. 1975 Oct 15;64(2):203–210. doi: 10.1016/0009-8981(75)90202-8. [DOI] [PubMed] [Google Scholar]
- Hawkins R. A., Hill A., Freedman B., Gore S. M., Roberts M. M., Forrest A. P. Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer. 1977 Sep;36(3):355–361. doi: 10.1038/bjc.1977.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]